Skip to main content

Management of Aortic Atherothrombi

  • Chapter
  • First Online:
Diseases of the Aorta

Abstract

Management of aortic erythema thrombi could be a challenge. The management depends on the location of the thrombus as well as the thickness and appearance of it. Some are incidental findings on routine imaging, but others could be devastating like strokes and end-organ ischemia like renal infarction and acute lower extremity ischemia. The management could be medical or surgical. Most of these patients have multiple cardiovascular risk factors, emphasizing the importance of secondary prevention. This chapter will provide an overview about the management of aortic atherothrombi.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kips JG, Segers P, Van Bortel LM. Identifying the vulnerable plaque: a review of invasive and non-invasive imaging modalities. Artery Res. 2008;2:21–34.

    Article  Google Scholar 

  2. Kronzon I, Tunick PA. Aortic atherosclerotic disease and stroke. Circulation. 2006;114:63–75.

    Article  PubMed  Google Scholar 

  3. Capmany RP, Ibañez MO, Pesquer XJ. Complex atheromatosis of the aortic arch in cerebral infarction. Curr Cardiol Rev. 2010;6:184–93.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report From the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995;92:1355–74.

    Article  CAS  PubMed  Google Scholar 

  5. DeBakey ME, Lawrie GM, Glaeser DH. Patterns of atherosclerosis and their surgical significance. Ann Surg. 1985;201:115–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381–6.

    Article  CAS  PubMed  Google Scholar 

  7. Herisson F, Heymann MF, Chetiveaux M, Charrier C, Battaglia S, Pilet P, et al. Carotid and femoral atherosclerotic plaques have different morphology. Atherosclerosis. 2011;216:348–54.

    Article  CAS  PubMed  Google Scholar 

  8. Lieberman EH, Gerhard MD, Uehata A, Selwyn AP, Ganz P, Yeung A, et al. Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease. Am J Cardiol. 1996;78:1210–4.

    Article  CAS  PubMed  Google Scholar 

  9. Ren X, Ren L, Wei Q, Shao H, Chen L, Liu N. Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Cardiovasc Diabetol. 2017;16:52.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Yang L, Cong HL, Wang SF, Liu T. AMP-activated protein kinase mediates the effects of lipoprotein-associated phospholipase A2 on endothelial dysfunction in atherosclerosis. Exp Ther Med. 2017;13:1622–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Camejo G, Hurt-Camejo E, Wiklund O, Bondjers G. Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis. 1998;139:205–22.

    Article  CAS  PubMed  Google Scholar 

  12. Camejo G, Fager G, Rosengren B, Hurt-Camejo E, Bondjers G. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. J Biol Chem. 1993;268:14131–7.

    CAS  PubMed  Google Scholar 

  13. Eliason JL, Wainess RM, Proctor MC, Dimick JB, Cowan JA Jr, et al. A National and Single Institutional Experience in the contemporary treatment of acute lower extremity ischemia. Ann Surg. 2003;238:382–90.

    PubMed  PubMed Central  Google Scholar 

  14. Abbott WM, Maloney RD, McCabe CC, Lee CE, Wirthlin LS. Arterial embolism: A 44-year perspective. Am J Surg. 1982;143:460–4.

    Article  CAS  PubMed  Google Scholar 

  15. Verma H, Meda N, Vora S, George RK, Tripathi RK. Contemporary management of symptomatic primary aortic mural thrombus. J Vasc Surg. 2014;60:1524–34.

    Article  PubMed  Google Scholar 

  16. Khouzam RN, Salama L, Soufi MK, Khandekar A, Al-Mawed S. Showers of emboli from a large aortic root thrombus. J La State Med Soc. 2014;166:138–42.

    PubMed  Google Scholar 

  17. Pagni S, Trivedi J, Ganzel BL, Williams M, Kapoor N, Ross C, Slater AD. Thoracic aortic mobile thrombus: is there a role for early surgical intervention? Ann Thorac Surg. 2011;91:1875–81.

    Article  PubMed  Google Scholar 

  18. Katz ES, Tunick PA, Rusine H, Ribakove G, Spencer FC, Kronzon I. Protruding aortic atheromas predict stroke in elderly patients undergoing cardiopulmonary bypass: experience with intraoperative transesophageal echocardiography. J Am Coll Cardiol. 1992;20:70–7.

    Article  CAS  PubMed  Google Scholar 

  19. Owen DRJ, Lindsay AC, Choudhury RP, Fayad ZA. Imaging of Atherosclerosis. Annu Rev Med. 2011;62:25–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Ellahham S. Role of antiplatelet agents in the primary and secondary prevention of atherothrombotic events in high risk-patients. South Med J. 2008;101:273–83.

    Article  PubMed  Google Scholar 

  21. Karalis D, Quinn V, Victor MF, Ross JJ, Polansky M, Spratt KA, et al. Risk of catheter-related emboli in patients with atherosclerotic debris in the thoracic aorta. Am Heart J. 1996;131:1149–55.

    Article  CAS  PubMed  Google Scholar 

  22. Tunick PA, Kronzon I. Atheromas of the thoracic aorta: clinical and therapeutic update. J Am Coll Cardiol. 2000;35:545–54.

    Article  CAS  PubMed  Google Scholar 

  23. Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71–86.

    Article  Google Scholar 

  24. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348(9038):1329–39.

    Article  Google Scholar 

  25. Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, Ringelstein EB. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation. 2005;111(17):2233–40.

    Article  CAS  PubMed  Google Scholar 

  26. Bhatt DL, Fox KA, Kacke W, Berger PB, Black HR, Boden WE, et al. A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Am Heart J. 2005;150:401.

    Article  PubMed  Google Scholar 

  27. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation III randomized clinical trial. Lancet. 1996;7:633–8.

    Google Scholar 

  28. Ferrari E, Vidal R, Chevallier T, Baudouy M. Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants. J Am Coll Cardiol. 1999;35:1317–22.

    Article  Google Scholar 

  29. Vaughan CJ. Prevention of stroke and dementia with statins: Effects beyond lipid lowering. Am J Cardiol. 2003;91:23–9.

    Article  Google Scholar 

  30. Tunick PA, Nayar AC, Goodkin GM, Mirchandani S, Francescone S, Rosenzweig BP, et al. Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol. 2002;90:1320–5.

    Article  PubMed  Google Scholar 

  31. Corti R, Fayad ZA, Fuster V, Worthley SG, Helft G, Chesebro J, et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation. 2001;104:249–52.

    Article  CAS  PubMed  Google Scholar 

  32. Da Silva AR, Fraga-Silva RA, Stergiopulos N, Montecucco F, Mach F. Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis. Eur J Clin Investig. 2015;45:274–87.

    Article  Google Scholar 

  33. Yoshida H, Kisugi R. Mechanisms of LDL oxidation. Clin Chim Acta. 2010;411:1875–82.

    Article  CAS  PubMed  Google Scholar 

  34. Lansberg MG, O’Donnell MJ, Khatri P, Lang ES, Nguyen-Huynh MN, Schwartz NE, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e601S–36S.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Wareing TH, Davila-Roman VG, Daily BB, Murphy SF, Schechtman KB, et al. Strategy for the reduction of stroke incidence in cardiac surgical patients. Ann Thorac Surg. 1993;55:1400–7.

    Article  CAS  PubMed  Google Scholar 

  36. Yamanaka K, Nishina T, Kanemitsu N, Hirose K, Mizuno A, Nakatsuka D, et al. Total aortic arch replacement for severe atherosclerotic aortic aneurysms: consecutive 135 cases study. Kyobu Geka. 2013;66:948–51.

    PubMed  Google Scholar 

  37. Stern A, Tunick PA, Culliford AT, Lachmann J, Baumann FG, Kanchuger MS, et al. Protruding aortic arch atheromas: risk of stroke during heart surgery with and without aortic arch endarterectomy. Am Heart J. 1999;138:746–52.

    Article  CAS  PubMed  Google Scholar 

  38. Scott DJ, White JM, Arthurs Z. Endovascular management of a mobile thoracic aortic thrombus following recurrent distal thromboembolism: a case report and literature review. Vasc Endovasc Surg. 2014;48:246–50.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Li, R.D., Gomez, L.F., Inkollu, S.K., Rabbat, M.G., Bechara, C.F. (2019). Management of Aortic Atherothrombi. In: Dieter, R., Dieter Jr., R., Dieter III, R. (eds) Diseases of the Aorta . Springer, Cham. https://doi.org/10.1007/978-3-030-11322-3_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-11322-3_32

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-11321-6

  • Online ISBN: 978-3-030-11322-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics